Cargando…

Long non-coding RNA cyclin-dependent kinase inhibitor 2B antisense ribonucleic acid 1 is associated with in-stent restenosis and promotes human carotid artery smooth muscle cell proliferation and migration by sponging miR-143-3p

Carotid angioplasty and stenting (CAS) is an efficient therapeutic approach for carotid stenosis. However, in-stent restenosis (ISR) frequently occurs and seriously affects the therapeutic efficacy of CAS. Certain non-coding (nc)RNAs serve potential roles in ISR development and progression. Thus, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Huanhuan, Dong, Aiqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851615/ https://www.ncbi.nlm.nih.gov/pubmed/33603842 http://dx.doi.org/10.3892/etm.2021.9665

Ejemplares similares

Dysregulation of lncRNA SNHG1/miR-145 axis affects the biological function of human carotid artery smooth muscle cells as a mechanism of carotid artery restenosis
por: Ma, Huanhuan, et al.
Publicado: (2021)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

Fracture of a carotid stent and restenosis of common carotid artery
por: Wróbel, Wojciech, et al.
Publicado: (2013)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
por: Ryu, Jae-Chan, et al.
Publicado: (2023)

Clinical impact and predictors of carotid artery in-stent restenosis
por: Wasser, Katrin, et al.
Publicado: (2012)

Treatment of the Carotid In-stent Restenosis: A Systematic Review
por: Huang, Hao, et al.
Publicado: (2021)

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells
por: Cao, Chen, et al.
Publicado: (2021)

Inflammation and In-Stent Restenosis: The Role of Serum Markers and Stent Characteristics in Carotid Artery Stenting
por: Wasser, Katrin, et al.
Publicado: (2011)

Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting
por: Nguyen, Dat Tin, et al.
Publicado: (2022)

Role of carotid duplex in the assessment of carotid artery restenosis after endarterectomy or stenting
por: Szegedi, István, et al.
Publicado: (2023)

Calcification in original plaque and restenosis following carotid artery stenting
por: Katano, Hiroyuki, et al.
Publicado: (2017)

Prediction of Carotid In-Stent Restenosis by Computed Tomography Angiography Carotid Plaque-Based Radiomics
por: Cheng, Xiaoqing, et al.
Publicado: (2022)

Comparison of carotid endarterectomy and repeated carotid angioplasty and stenting for in-stent restenosis (CERCAS trial): a randomised study
por: Hrbáč, Tomáš, et al.
Publicado: (2023)

Aggressive In-Stent Restenosis after Carotid Artery Stenting in a Patient with HIV Infection
por: Kim, Dae Yeon, et al.
Publicado: (2021)

Cerebral collateral circulation as an independent predictor for in-stent restenosis after carotid artery stenting
por: Liu, Luji, et al.
Publicado: (2023)

Diagnostic value of microRNA-143 in predicting in-stent restenosis for patients with lower extremity arterial occlusive disease
por: Yu, Zhi-Hai, et al.
Publicado: (2017)

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
por: Simsekyilmaz, Sakine, et al.
Publicado: (2013)

Carotid endarterectomy for in-stent restenosis: a case report and literature review
por: Xu, Baofeng, et al.
Publicado: (2017)

Associations between preprocedural carotid artery perivascular fat density and early in-stent restenosis after carotid artery stenting
por: Hu, Jun, et al.
Publicado: (2023)

Carotid endarterectomy with stent removal for recurring in-stent restenosis: A case report and literature review
por: Takahashi, Yuichi, et al.
Publicado: (2022)

Impact of Diabetes Mellitus on Early Clinical Outcome and Stent Restenosis after Carotid Artery Stenting
por: Achim, Alexandru, et al.
Publicado: (2022)

Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis
por: Gaudry, Marine, et al.
Publicado: (2016)

In-stent graft restenosis in the carotid artery. What is your opinion about this patient?
por: Tatli, Ersan, et al.
Publicado: (2016)

The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro
por: Kastl, Stefan P., et al.
Publicado: (2020)

Percutaneous Treatment of Recurrent In-Stent Restenosis of Carotid Artery Stenting: A Case Report and State-of-the-Art Review
por: Di Gioia, Giuseppe, et al.
Publicado: (2015)

Middle and Distal Common Carotid Artery Stenting: Long-Term Patency Rates and Risk Factors for In-Stent Restenosis
por: Vértes, Miklós, et al.
Publicado: (2020)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Long Non-Coding RNAs Might Regulate Phenotypic Switch of Vascular Smooth Muscle Cells Acting as ceRNA: Implications for In-Stent Restenosis
por: Arencibia, Alberto, et al.
Publicado: (2022)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial
por: Bonati, Leo H, et al.
Publicado: (2018)

Defining Duplex Ultrasound Criteria for In-Stent Restenosis of the Carotid Artery Using Computed Tomographic Angiography
por: Bitsko, Lucas J, et al.
Publicado: (2022)

Circulating long non‐coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer
por: Zhang, Yi, et al.
Publicado: (2016)

Plasma levels of miR-143 and miR-145 are associated with coronary in-stent restenosis within 1 year of follow-up after drug-eluting stent implantation
por: Yuan, Yuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4jmngdp08p3331h0aantkqalg9